CoChat
Sign Up
Cited by 42Psoriasis: Treatment and PathogenesisDermatology and Skin DiseasesSpondyloarthritis Studies and Treatments

Impact of psoriasis on quality of life in Iran

Open access
Aghaei, Shahin, Moradi, Ahmad, Ardekani, GholamrezaSafaee·2009·Indian Journal of Dermatology, Venereology and Leprology
DOI 10.4103/0378-6323.48689
Open this paper in CoChat — free account

Abstract

BACKGROUND: The Psoriasis Disability Index (PDI) questionnaire is a widely used instrument to measure psychological morbidity in plaque-type psoriasis patients. AIMS: This study aimed to validate the Persian version of the PDI and to evaluate the impact of psoriasis on quality of life (QOL). METHODS: The English language version of the PDI was translated into Persian (Iranian official language) and was used in this study. The questionnaire was administered to a consecutive sample of 125 chronic plaque-type psoriasis patients and statistical analysis was performed to evaluate the impact of psoriasis on QOL. The other health-related QOL assessment tool included the Persian version of the Dermatology Life Quality Index (DLQI). RESULTS: Overall, 125 patients who had received the PDI and DLQI completed all the questions. Reliability analysis showed a satisfactory result (Cronbach's a coefficient=0.92 and 0.79 for PDI and DLQI, respectively). There was a strong statistical correlation between mean PDI and DLQI scores, with mean Psoriasis Area and Severity Index (PASI) (P=0.005 and 0.02). Also, a significant correlation coefficient existed between DLQI and PDI (r=0.94). The higher the PASI index, the higher the PDI and DLQI scores, which indicated greater impact on QOL. In the patients with lesions on visible exposed skin areas, the correlation was statistically significant (P=0.002 and 0.01). CONCLUSION: The Persian PDI is an acceptable, reliable and valid measure of psychological distress, with more suitable content validity than DLQI for assessment of impact of psoriasis on QOL among psoriasis patients. Data provided may improve the physicians' awareness of the importance of the patients' QOL.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/0378-6323.48689

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical severity measured by clinicians using formal grading scales does not always correlate with patients' perceptions of severity, and the discrepancy appears disease-specific.

    “clinical severity, as measured by clinicians using formal grading scales, does not always correlate with patients’ perceptions of their condition’s severity. The discrepancy appears to be disease-specific.”

    From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [18]

  • Clinical severity of psoriasis correlates more to patient perception due to the presence of comorbid psoriatic arthritis.

    “The clinical severity of psoriasis correlates more to patient perception due to the presence of comorbid psoriatic arthritis”

    From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Still being checked.

Research works printed but not linked: 26

  1. [2]2. Calman KC. Quality of life in cancer patients-hypothesis. J Med Ethics 1984;10:124-7.
  2. [3]3. Price P , Harding KG. Defining quality of life. J Wound Care 1993;2:304-6.
  3. [4]4. De Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: A systematic literature review. J Invest Dermatol Symp Proc 2004;9:140-7.
  4. [5]5. Fortune DG, Main CJ, O Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997;137:766-70.
  5. [6]6. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. Indian J Dermatol Venereol Leprol | March-April 2009 | Vol 75 | Issue 2 - The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
  6. [7]7. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-7.
  7. [8]8. Fried RG, Friedman S, Paradis C, Hatach M, Lynfield Y, Duncanson C, et al . Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101-5.
  8. [9]9. Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002;16:34752.
  9. [10]10. Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-90.
  10. [11]11. Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, DeRie MA. The burden of psoriasis is not determined by disease severity only. J Invertig Dermatol Symp Proc 2004;9:131-5.
  11. [12]12. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or patient? Br J Cancer 1988;57:109-12.
  12. [13]13. Marks R, Barton SP , Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:23540.
  13. [14]14. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
  14. [15]15. Aghaei S, Sodaifi M, Jafari P , Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004;4:8.
  15. [16]16. Nunnally JC. Psychometric theory. New York: McGraw-Hill; 1978.
  16. [18]18. Finlay AY, Kelly SE. Psoriasis: An index of disability. Clin Exp Dermatol 1987;12:8-11.
  17. [19]19. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:23644.
  18. [20]20. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751-6.
  19. [21]21. Salek MS, Finlay AY. Cyclosporin improves quality of life in psoriasis: Does this matter? Br J Dermatol 1993;129:32.
  20. [22]22. Root S, Kent G, Al-Abadie MS. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994;189:234-7.
  21. [23]23. Kent G, Al-Abadie M. The psoriasis disability index: Further analyses. Clin Exp Dermatol 1993;18:414-6.
  22. [24]24. Parry EJ, Tillman DM, Long J. Audit of UVB phototherapy in the treatment of psoriasis. Br J Dermatol 1995;133:16.
  23. [26]26. Picardi A, Abeni D, Melchi C, Puddu P , Pasquini P . Psychiatric morbidity in dermatological outpatients: An issue to be recognized. Br J Dermatol 2000;143:983-91.
  24. [27]27. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143:51-4.
  25. [28]28. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients reffered to a dermatologypsychiatry clinic. Gen Hosp Psychiatry 1997;19:29-35.
  26. [29]29. Stein KR, Pearce DJ, Feldman SR. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care. Semin Cutan Med Surg 2005;24:52-7. 233

Cited by

Sorted by citations

Related

Authors
Aghaei, S., Moradi, A., & Ardekani, G.
Affiliations
  • Jahrom University of Medical Sciences (IR)
  • Shiraz University of Medical Sciences (IR)
Venue
Indian Journal of Dermatology, Venereology and Leprology
Publisher
Scientific Scholar
Published
2009
Volume
75
Issue
2
Pages
220
ISSN
0378-6323 (ISSN-L)
DOI
10.4103/0378-6323.48689
OpenAlex
W2038973534
Cited by
42
References
0
Citations by year
2025: 2 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 1
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • Indian Journal of Dermatology Venereology and Leprology (publishedVersion)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion)
  • Bioline International (Bioline International) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
Keywords
psoriasis, quality of life, Psoriasis Disability Index, Persian translation, questionnaire validation, Dermatology Life Quality Index, psychological distress, plaque psoriasis, PASI, Iranian patients
MeSH terms
Adolescent, Adult, Female, Humans, Iran, Male, Middle Aged, Psoriasis, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Reproducibility of Results, Multilingualism, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review